For: | Zhang J, Tan SB, Guo ZG. CD47 decline in pancreatic islet cells promotes macrophage-mediated phagocytosis in type I diabetes. World J Diabetes 2020; 11(6): 239-251 [PMID: 32547698 DOI: 10.4239/wjd.v11.i6.239] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v11/i6/239.htm |
Number | Citing Articles |
1 |
Kaiyven Afi Leslie, Sarah J. Richardson, Mark A. Russell, Noel G. Morgan. Expression of CD47 in the pancreatic β‐cells of people with recent‐onset type 1 diabetes varies according to disease endotype. Diabetic Medicine 2021; 38(12) doi: 10.1111/dme.14724
|
2 |
Victoria C. Brom, Christof Burger, Dieter C. Wirtz, Frank A. Schildberg. The Role of Immune Checkpoint Molecules on Macrophages in Cancer, Infection, and Autoimmune Pathologies. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.837645
|
3 |
Xi Su, Wenwen Jin, Lizhi Liu, Zifei Zhu, Cunyan Li. Regulation of CD47 expression on CD14+ monocytes by interferon-α in PBC patients. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1256995
|
4 |
Wencheng Zhang, Shuo Yang, Xinwen Yu, Shanshan Zhu, Xin Wang, Fei Sun, Shengru Liang, Xiaoguang Wang, Guohong Zhao, Bin Gao. Beneficial Actions of 4-Methylumbelliferone in Type 1 Diabetes by Promoting β Cell Renewal and Inhibiting Dedifferentiation. Biomedicines 2024; 12(12): 2790 doi: 10.3390/biomedicines12122790
|
5 |
Shuang Yang, Ming Zhao, Sujie Jia. Macrophage: Key player in the pathogenesis of autoimmune diseases. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1080310
|
6 |
Jeffrey S. Isenberg, Enrique Montero. Tolerating CD47. Clinical and Translational Medicine 2024; 14(2) doi: 10.1002/ctm2.1584
|
7 |
Wei-Qing Deng, Zi-Han Ye, Zhenghai Tang, Xiao-Lei Zhang, Jin-Jian Lu. Beyond cancer: The potential application of CD47-based therapy in non-cancer diseases. Acta Pharmaceutica Sinica B 2025; 15(2): 757 doi: 10.1016/j.apsb.2024.11.018
|
8 |
Xin Chen, Hong An, Yongbiao Du, Hao Zhong, Fangfang Zhang, Xiaomei Zeng, Fen Lv, Zhihua Tian, Zaixue Jiang, Qi Peng, Zengbao Li, Siping Li, Baimao Zhong, Xiaomei Lu, Yinghua Zhu. hucMSC-derived exosomes targeting macrophage polarization attenuate systemic inflammation in T1DM via INS/SOD1 delivery. Stem Cell Research & Therapy 2025; 16(1) doi: 10.1186/s13287-025-04521-0
|
9 |
Henriette Reventlow Frederiksen, Alexandra Glantz, Kåre Kryger Vøls, Søren Skov, Pernille Tveden-Nyborg, Kristine Freude, Ulrik Doehn. CRISPR-Cas9 immune-evasive hESCs are rejected following transplantation into immunocompetent mice. Frontiers in Genome Editing 2024; 6 doi: 10.3389/fgeed.2024.1403395
|
10 |
Tobias Deuse, Sonja Schrepfer. Progress and challenges in developing allogeneic cell therapies. Cell Stem Cell 2025; 32(4): 513 doi: 10.1016/j.stem.2025.03.004
|
11 |
David D. Roberts, Jeffrey S. Isenberg. CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and diabetes. American Journal of Physiology-Cell Physiology 2021; 321(2): C201 doi: 10.1152/ajpcell.00175.2021
|
12 |
Robert C. Sharp, Matthew E. Brown, Melanie R. Shapiro, Amanda L. Posgai, Todd M. Brusko. The Immunoregulatory Role of the Signal Regulatory Protein Family and CD47 Signaling Pathway in Type 1 Diabetes. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.739048
|